Laboratório Teuto Brasileiro S/A   Report issue

For profit Phase 3
Founded: Anapolis Brazil (1947)
Status: No NME R&D (1947)

Organization Overview

First Clinical Trial
2011
NCT01373697
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (5)

diosmetine (1 trial)

Hesperedin (1 trial)

ibuprofen (motrin) (1 trial)

sildenafil (viagra) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 3)

Communicable Diseases (Phase 3)

Erectile Dysfunction (Phase 3)

Infections (Phase 3)

Muscular Atrophy (Phase 3)

Mycoses (Phase 3)

Sprains and Strains (Phase 3)

Tendinopathy (Phase 3)

Tinea (Phase 3)

Tinea Pedis (Phase 3)

Venous Insufficiency (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 5